الفهرس 
TitleOnly 14 pages are availabe for public view
 |  | from | 58 |  |  |
| | | from | 58 | | |
Abstract
Morbid obesity poses technical difficulties and challenges to surgeons at open surgery, it was therefore considered by some surgeons to be a relative contraindication to laparoscopic surgery. It is considered as a risk factor for the increase in the operative time, anesthetic complications, laparoscopic bile duct injuries, and the conversion to open cholecystectomy. It has also been proven to be one of the major risk factors for cholelithiasis, and its incidence is significantly increasing worldwide. Therefore, surgeons are increasingly likely to encounter a growing number of obese patients who require cholecystectomy for symptomatic cholelithiasis. Although there is growing evidence on the safety and efficacy of LC in the obese patients, there is a lack of data on its use in the morbid obese patients. The aim of this work is to compare the feasibility and early outcome of laparoscopic cholecystectomy in morbidly obese patients versus non obese patients.
This study included 40 patients admitted to the department of surgery, Alexandria Medical Research Institute who were planned for elective laparoscopic cholecystectomy. Patients were divided into 2 groups according to their BMI: group I were 20 non-obese patients with BMI <30, group II were 20 morbidly obese patients with BMI >40. A prospective analysis of demographics, preoperative data, BMI, laboratory and imaging data, duration of surgery (DOS), intraoperative complications, length of hospital stay (LOS), and postoperative events was performed.
There was a significant increase in DOS in group II than in group I (p <0.05). The insufflation pressure was also significantly higher in group II more than group I (p < 0.05). Yet, there were no statistically significant differences in LOS, intraoperative, or postoperative complications between the two groups.
We conclude that laparoscopic cholecystectomy in the morbidly obese patients, needs longer intraoperative time, relatively higher insufflation pressure but it does not increase the intraoperative, postoperative complications, nor the length of hospital stay. Therefore, it is feasible and safe in the morbidly obese patients.